Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Operating Expenses (2016 - 2020)

Historic Operating Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to $8.7 million.

  • Forte Biosciences' Operating Expenses fell 4847.75% to $8.7 million in Q1 2020 from the same period last year, while for Dec 2020 it was $8.7 million, marking a year-over-year decrease of 8586.93%. This contributed to the annual value of $61.5 million for FY2019, which is 366.57% down from last year.
  • According to the latest figures from Q1 2020, Forte Biosciences' Operating Expenses is $8.7 million, which was down 4847.75% from $10.7 million recorded in Q4 2019.
  • In the past 5 years, Forte Biosciences' Operating Expenses registered a high of $19.1 million during Q4 2018, and its lowest value of $7.6 million during Q1 2016.
  • Moreover, its 5-year median value for Operating Expenses was $10.7 million (2017), whereas its average is $12.0 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 7872.1% in 2018, then crashed by 4847.75% in 2020.
  • Over the past 5 years, Forte Biosciences' Operating Expenses (Quarter) stood at $8.0 million in 2016, then skyrocketed by 33.95% to $10.7 million in 2017, then soared by 78.72% to $19.1 million in 2018, then crashed by 43.97% to $10.7 million in 2019, then fell by 18.8% to $8.7 million in 2020.
  • Its Operating Expenses was $8.7 million in Q1 2020, compared to $10.7 million in Q4 2019 and $17.1 million in Q3 2019.